Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase EARLY_PHASE1 3Phase 1 3Phase 3 2Phase 1/2 2Phase NA 1Phase 4 1Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 4Gynecologic 3Breast 3Other 2Genitourinary 2Gastrointestinal 2Thoracic 1NET 1Endocrine 1CNS 1

Conditions

Endometrial Neoplasms 2Ovarian Neoplasms 1Insulin Resistance 1

Interventions

olaparib 6Specimen Handling 5Paclitaxel 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 4Carboplatin 4pembrolizumab 3fludarabine 3X-Rays 3Taxes 3Metformin 3Letrozole 3Fluorodeoxyglucose F18 3Biopsy 3Aspirin 3niraparib 2Tirzepatide 2Radiotherapy 2Propranolol 2Platinum 2Pafolacianine 2Oncolytic Virotherapy 2Hysterectomy 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorescein 2Drug Therapy 2Doxorubicin 2Cytoreduction Surgical Procedures 2Cisplatin 21,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Metformin × Gynecologic × Clear all
NCT03378297 2024-10-30

IMPACT

Haukeland University Hospital

Phase EARLY_PHASE1 Completed
26 enrolled
Gynecologic

Ovarian Neoplasms

NCT01205672 2017-06-02

Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
21 enrolled
Gynecologic

Insulin Resistance, Endometrial Neoplasms

NCT01911247 2013-07-30

Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
28 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡